Inventor · disambiguated record
Stephen Cusack
Also filed as: CUSACK STEPHEN
14 granted patents·19 pending applications·16 citations·filing 2000–2022
86Inventor score
Files withSAVIRA PHARMACEUTICALS GMBH10HOFFMANN LA ROCHE9EUROPEAN MOLECULAR BIOLOGY LABORATORY (EMBL)4CUSACK STEPHEN2F HOFFMANN-LA ROCHE LTD2
Top patents by PatentIndex Score
33 records- 0180US6740511B1Modified adenoviral fibre and uses thereofTRANSGENE SA·Filed 2000·Granted May 25, 2004·10 cites·5 claims
- 0278US9827244B2Cap/endo dual inhibitors and their use in the treatment, amelioration or prevention of a viral diseaseHOFFMANN LA ROCHE·Filed 2016·Granted Nov 28, 2017·3 cites·20 claims
- 0370US8921388B2Dihydroxypyrimidine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2013·Granted Dec 30, 2014·2 cites·28 claims
- 0463US9434745B27-oxo-thiazolopyridine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2013·Granted Sep 6, 2016·1 cites·14 claims
- 0562US9199987B2Substituted naphthyridines for the treatment, amelioration or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2014·Granted Dec 1, 2015·0 cites·8 claims
- 0658US9505758B2Substituted 1,5-naphthyridines as endonuclease inhibitorsSAVIRA PHARMACEUTICALS GMBH·Filed 2015·Granted Nov 29, 2016·0 cites·5 claims
- 0756US2022142504A1Method and device for respiratory monitoringPMD DEVICE SOLUTIONS LTD·Filed 2022·Application pending·0 cites
- 0856US2012108493A1Polypeptide Fragments Comprising Endonuclease Activity and Their UseBOUVIER DENIS·Filed 2009·Application pending·0 cites
- 0955US2017290834A1Naphthyridinone derivatives and their use in the treatment, amelioration or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2016·Application pending·0 cites
- 1053US2004038205A1Modified adenoviral fiber and usesTRANSGENE SA·Filed 2003·Application pending·0 cites
- 1152US9890368B2Polypeptide fragments comprising endonuclease activity and their useEUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL·Filed 2014·Granted Feb 13, 2018·0 cites·18 claims
- 1251US2013102601A1Pyrimidin-4-one derivatives and their use in the treatment, amelioration or prevention of a viral diseaseHOFFMANN LA ROCHE·Filed 2012·Application pending·0 cites
- 1350US2018044649A1Influenza a 2009 pandemic h1n1 polypeptide fragments comprising endonuclease activity and their useEUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL·Filed 2017·Application pending·0 cites
- 1449US2013102600A1Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral diseaseHOFFMANN LA ROCHE·Filed 2012·Application pending·0 cites
- 1548US9783794B2Influenza A 2009 pandemic H1N1 polypeptide fragments comprising endonuclease activity and their useEUROPEAN MOLECULAR BIOLOGY LABORATORY (EMBL)·Filed 2015·Granted Oct 10, 2017·0 cites·14 claims
- 1648US9359351B2Cap/endo dual inhibitors and their use in the treatment, amelioration or prevention of a viral diseaseHOFFMANN LA ROCHE·Filed 2015·Granted Jun 7, 2016·0 cites·19 claims
- 1747US9181307B2Influenza A 2009 pandemic H1N1 polypeptide fragments comprising endonuclease activity and their useCUSACK STEPHEN·Filed 2011·Granted Nov 10, 2015·0 cites·14 claims
- 1847US2016362423A17-oxo-thiazolopyridine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2016·Application pending·0 cites
- 1943US11259716B2Method and device for respiratory monitoringPMD DEVICE SOLUTIONS LTD·Filed 2014·Granted Mar 1, 2022·0 cites·18 claims
- 2043US8952039B2Pyridone derivatives and their use in the treatment, ameloriation or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2014·Granted Feb 10, 2015·0 cites·13 claims
- 2143US2013317021A1Heterocyclic pyrimidine carbonic acid derivatives which are useful in the treatment, amelioration or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2013·Application pending·0 cites
- 2242US9045486B2Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2014·Granted Jun 2, 2015·0 cites·13 claims
- 2342US2016297763A1Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral diseaseF HOFFMANN-LA ROCHE LTD·Filed 2016·Application pending·0 cites
- 2441US2017081323A1Triazolones derivatives for use in the treatment, amelioration or prevention of a viral diseaseHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 2541US2017081331A1Pyrazolopyrazines and their use in the treatment, amelioration or prevention of a viral diseaseHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 2641US2018010109A1Polypeptide fragments comprising endonuclease activity and their useEUROPEAN MOLECULAR BIOLOGY LABORATORY (EMBL)·Filed 2017·Application pending·0 cites
- 2738US9045248B2Soluble fragments of influenza virus PB2 protein capable of binding RNA-capCUSACK STEPHEN·Filed 2008·Granted Jun 2, 2015·0 cites·14 claims
- 2838US2016367557A1Heterocyclic pyrimidine carbonic acid derivatives which are useful in the treatment, amelioration or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2016·Application pending·0 cites
- 2936US2017100396A1Pyrrolopyrazine derivatives for use in the treatment, amelioration or prevention of influenzaHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 3036US2016376286A1Pyrimidin-4-one derivatives and their use in the tratement, amelioration or prevention of a viral diseaseF HOFFMANN-LA ROCHE LTD·Filed 2016·Application pending·0 cites
- 3135US2017081324A1Triazolones derivatives and their use in the treatment, amelioration or prevention of a viral diseaseHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 3234US2019252037A1Viral Polypeptide Fragments That Bind Cellular POL II C-Terminal Domain (CTD) and Their UsesTHE EUROPEAN MOLECULAR BIOLOGY LABORATORY·Filed 2017·Application pending·0 cites
- 3332US2016002226A1Pyridopyrazine compounds and their use in the treatment, amelioration or prevention of influenzaHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stephen Cusack files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →